228670.KQ
Ray Co., Ltd.
KOE · Healthcare · Medical - Specialties · KR
KRW 4,795.00
−0.42%Year over year
Reported trailing growth
- Revenue
- +32.8%
- EBITDA
- +194.2%
- EBIT
- +70.9%
- EPS
- +124.2%
- Free cash flow
- +58.7%
- Operating cash flow
- +56.8%
Forward estimates
Based on analyst estimates
- Revenue
- -16.3%
- EBITDA
- +74.5%
- EPS
- +45.7%
Three-year CAGR
- Revenue
- -4.8%
- EBITDA
- +98.3%
- EBIT
- +77.9%
- Net income
- -26.7%
- EPS
- -28.2%
- Free cash flow
- +488.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026